Xencor (XNCR) Share-based Compensation (2013 - 2026)

Xencor's (XNCR) quarterly Share-based Compensation came in at $9.6 million in Q1 2026, down 21.71% year-on-year from $12.2 million in Q1 2025, and down 6.13% on a QoQ basis from $10.2 million in Q4 2025.

Xencor (XNCR) Share-based Compensation (2013 - 2026) Analysis & Trends

Xencor (XNCR) has 14 years of Share-based Compensation data on file, last reported at $9.6 million in Q1 2026.

  • On a quarterly basis, Share-based Compensation fell 21.71% year-over-year to $9.6 million in Q1 2026; TTM through Mar 2026 was $40.6 million, a 24.96% decrease from a year earlier, with the FY2025 full-year figure at $43.2 million, down 18.87% from the prior year.
  • Share-based Compensation for Q1 2026 stood at $9.6 million, down from $10.2 million in the prior quarter.
  • Over the last five years, Share-based Compensation for XNCR reached as high as $51.3 million in Q4 2023 and fell as low as -$30.0 million in Q4 2022.
  • Historically, Share-based Compensation has averaged $11.9 million across 5 years, with a median of $12.3 million in 2024.
  • On a YoY basis, Share-based Compensation climbed as much as 1295.68% in 2022 and fell as far as 1082.08% in 2022.
  • Year by year, Share-based Compensation stood at -$30.0 million in 2022, then surged by 270.9% to $51.3 million in 2023, then sank by 75.96% to $12.3 million in 2024, then retreated by 17.41% to $10.2 million in 2025, then declined by 6.13% to $9.6 million in 2026.
  • Per Business Quant data, the three most recent Share-based Compensation figures were $9.6 million in Q1 2026, $10.2 million in Q4 2025, and $10.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 6.39 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9.26 Mn
4 NuCana 279.75 Bn 279.75 Bn - 1.18 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 166.40 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 257.40 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 87.30 Mn
10 Xencor 1.47 Bn 1.09 Bn - 9.56 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 9.56 Mn
Mar 31, 2026 9.56 Mn
Dec 31, 2025 10.19 Mn
Dec 31, 2025 10.19 Mn
Sep 30, 2025 10.09 Mn
Sep 30, 2025 10.09 Mn
Jun 30, 2025 10.74 Mn
Jun 30, 2025 10.74 Mn
Mar 31, 2025 12.21 Mn
Mar 31, 2025 12.21 Mn
Dec 31, 2024 12.33 Mn
Dec 31, 2024 12.33 Mn
Sep 30, 2024 12.34 Mn
Sep 30, 2024 12.34 Mn
Jun 30, 2024 17.19 Mn
Jun 30, 2024 17.19 Mn
Mar 31, 2024 11.42 Mn
Mar 31, 2024 11.42 Mn
Dec 31, 2023 51.29 Mn
Dec 31, 2023 51.29 Mn